Oral Presentations - Late-Breaking Proffered Abstracts最新文献

筛选
英文 中文
5PSQ-121 Cytokine release syndrome related to the treatment with teclistamab: a case report 与替司他抗治疗相关的5PSQ-121细胞因子释放综合征1例
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.457
L. Torralba, N. Labrador, M. Toledo, C. Jiménez, R. Prieto, A. Rubio, A. Domínguez, P. Moya
{"title":"5PSQ-121 Cytokine release syndrome related to the treatment with teclistamab: a case report","authors":"L. Torralba, N. Labrador, M. Toledo, C. Jiménez, R. Prieto, A. Rubio, A. Domínguez, P. Moya","doi":"10.1136/ejhpharm-2023-eahp.457","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.457","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81936154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-069 Experience of onco-haematology patients in outpatient therapy with comprehensive medication management in the context of a COVID 19 pandemic 2019冠状病毒病大流行背景下肿瘤合并血液病患者门诊综合用药治疗的体会
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.387
V. Vázquez Vela, V. Sánchez-Matamoros Piazza, C. Bermúdez Tamayo, M. L. López Muñoz, C. Cuadros Martínez, MM Silva Castro
{"title":"4CPS-069 Experience of onco-haematology patients in outpatient therapy with comprehensive medication management in the context of a COVID 19 pandemic","authors":"V. Vázquez Vela, V. Sánchez-Matamoros Piazza, C. Bermúdez Tamayo, M. L. López Muñoz, C. Cuadros Martínez, MM Silva Castro","doi":"10.1136/ejhpharm-2023-eahp.387","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.387","url":null,"abstract":"Background and ImportanceThe opening of a pharmaceutical care service for onco-haematology patients (OHP) in the midst of the health care crisis caused by the COVID19 pandemic, made it possible to maintain the healthcare activity, avoid the collapse and provide the opportunity to implement Comprehensive Medication Management (CMM).Aim and ObjectivesTo investigate the pharmacotherapeutic experience of OHP in outpatient therapy with CMM services;to know important aspects perceived for the identification of barriers/facilitators that determine the quality of the service and proposals for improvement.Material and MethodsDescriptive observational design with a qualitative approach, using informal and semi-structured in-depth interviews (participant observation and peer review) during January-June 2021. ATLAS.ti software was used for content analysis. Oncohaematology patients in outpatient therapy with any medication-related problem and who received CMM services were interviewed. Those who, due to cognitive limitation, could not be interviewed or who did not have a caregiver/family member available were excluded.Results19 interviews were conducted: 57.89% patients and 42.10% caregivers;57.89% were women. All patients were very satisfied with the care received, the vast majority preferred to be attended by a pharmacist, and valued telepharmacy as an alternative or complementary option. The vision of the pharmacy professional as an expert in medicines improves. They suggest improvement related to location, waiting times and greater accessibility of the pharmacist. After the researchers' reflective process, were identified as barriers: care pressure, limited time/resources, lack of interlevel coordination, and facilitators: prioritisation of interventions, integration of pharmacist in the multidisciplinary team, trust in the pharmacist and the new model of care. Improvement strategies: provision of human/material resources with release of pharmacist's time to provide the CMM, extension of hours, information management with the development of personal learning environment and use of programs for recording/integration of information and interventions.Conclusion and RelevanceDelving into patients‘ experiences can be key to improving the quality of care. In our case, the implementation of the CMM service in OHP has been a challenge and an opportunity in the current context of the COVID-19 pandemic. The pharmacy adapted to the needs and implemented a new model of care with excellent acceptance by users.References and/or AcknowledgementsConflict of InterestNo conflict of interest","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84050802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-114 Persistence and level of clearance in patients with moderate-to-severe psoriasis treated with guselkumab 5PSQ-114治疗中重度银屑病患者的持续性和清除水平
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.455
G. Calzado Gómez, MA Navarro Dávila, S. Perez Reyes, C. Romero Delgado, S. Otazo Perez, Y. González Pérez, M. Bullejos Molina, G. Nazco Casariego
{"title":"5PSQ-114 Persistence and level of clearance in patients with moderate-to-severe psoriasis treated with guselkumab","authors":"G. Calzado Gómez, MA Navarro Dávila, S. Perez Reyes, C. Romero Delgado, S. Otazo Perez, Y. González Pérez, M. Bullejos Molina, G. Nazco Casariego","doi":"10.1136/ejhpharm-2023-eahp.455","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.455","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78670931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-064 Effectiveness of ribociclib and abemaciclib as first line treatment for metastatic breast cancer in post-menopausal women ribociclib和abemaciclib作为绝经后妇女转移性乳腺癌一线治疗的有效性
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.386
Mdp Briceño Casado, MD Gil-Sierra, C. Cuadros-Martinez, B. de la Calle-Riaguas, R. Gavira-Moreno
{"title":"4CPS-064 Effectiveness of ribociclib and abemaciclib as first line treatment for metastatic breast cancer in post-menopausal women","authors":"Mdp Briceño Casado, MD Gil-Sierra, C. Cuadros-Martinez, B. de la Calle-Riaguas, R. Gavira-Moreno","doi":"10.1136/ejhpharm-2023-eahp.386","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.386","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88124561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-224 Impact of augmented renal clearance on antimicrobial dosing in severely burned patients 增强肾脏清除率对严重烧伤患者抗菌药物剂量的影响
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.422
J. Llata, D. Anguita, A. Arévalo, P. Lalueza, J. Juárez, J. Serracanta, S. Marquina, J. Baena
{"title":"4CPS-224 Impact of augmented renal clearance on antimicrobial dosing in severely burned patients","authors":"J. Llata, D. Anguita, A. Arévalo, P. Lalueza, J. Juárez, J. Serracanta, S. Marquina, J. Baena","doi":"10.1136/ejhpharm-2023-eahp.422","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.422","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"1 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91423593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6ER-018 Off-label use of ustekinumab in refractory epidermolytic ichthyosis: a case report 6ER-018超说明书使用ustekinumab治疗难治性表皮松解性鱼鳞病:1例报告
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.470
P. Ciudad Gutiérrez, Á. Villalba Moreno, MT Montserrat García, S. Flores Moreno, L. Rodríguez De Francisco, ER Alfaro Lara
{"title":"6ER-018 Off-label use of ustekinumab in refractory epidermolytic ichthyosis: a case report","authors":"P. Ciudad Gutiérrez, Á. Villalba Moreno, MT Montserrat García, S. Flores Moreno, L. Rodríguez De Francisco, ER Alfaro Lara","doi":"10.1136/ejhpharm-2023-eahp.470","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.470","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78536642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6ER-006 Current performance of hospital pharmacy specialists trained at a tertiary hospital in Spain 6ER-006西班牙某三级医院接受培训的医院药学专家的现状
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.465
B. Santos Ramos, H. Rodríguez-Ramallo, A. Rodríguez-Pérez, L. Rodríguez Defrancisco, M. Fernández González
{"title":"6ER-006 Current performance of hospital pharmacy specialists trained at a tertiary hospital in Spain","authors":"B. Santos Ramos, H. Rodríguez-Ramallo, A. Rodríguez-Pérez, L. Rodríguez Defrancisco, M. Fernández González","doi":"10.1136/ejhpharm-2023-eahp.465","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.465","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"257 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72952828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-112 Relationship between effectiveness and immune-mediated toxicity of immune check-point inhibitors in advanced non-small-cell lung cancer 免疫检查点抑制剂治疗晚期非小细胞肺癌疗效与免疫介导毒性的关系
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.454
G. Miron Elorriaga, Y. Viseda Torrellas, M. Palacios Filardo, M. Cardenas Sierra, FJ Goikolea Ugarte, A. Martin Torrente, L. Torio Alvarez, O. Ibarra Barrueta, P. Gemio Zumalave, M. Carmona Oyaga, A. Gomez De Segura Sarobe
{"title":"5PSQ-112 Relationship between effectiveness and immune-mediated toxicity of immune check-point inhibitors in advanced non-small-cell lung cancer","authors":"G. Miron Elorriaga, Y. Viseda Torrellas, M. Palacios Filardo, M. Cardenas Sierra, FJ Goikolea Ugarte, A. Martin Torrente, L. Torio Alvarez, O. Ibarra Barrueta, P. Gemio Zumalave, M. Carmona Oyaga, A. Gomez De Segura Sarobe","doi":"10.1136/ejhpharm-2023-eahp.454","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.454","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"80 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83829949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-033 Evaluation of the effectiveness of reinduction or intensification with ustekinumab in inflammatory bowel disease 评价ustekinumab再诱导或强化治疗炎症性肠病的有效性
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.379
M. Falcón Cubillo, L. Rodríguez-de Francisco, Á. Órpez-Ramírez, A. Rodríguez-Pérez, A. Villalba-Moreno, M. López-Feijoó, M. Fernández-González
{"title":"4CPS-033 Evaluation of the effectiveness of reinduction or intensification with ustekinumab in inflammatory bowel disease","authors":"M. Falcón Cubillo, L. Rodríguez-de Francisco, Á. Órpez-Ramírez, A. Rodríguez-Pérez, A. Villalba-Moreno, M. López-Feijoó, M. Fernández-González","doi":"10.1136/ejhpharm-2023-eahp.379","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.379","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"89 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82230301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1ISG-003 Protocol for the optimisation of pharmaceutical validation in hospitalised patients 1ISG-003住院患者药物验证优化方案
Oral Presentations - Late-Breaking Proffered Abstracts Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.356
R. Claramunt García, M. Merino Almazán, T. Sánchez Casanueva, N. García Gomez
{"title":"1ISG-003 Protocol for the optimisation of pharmaceutical validation in hospitalised patients","authors":"R. Claramunt García, M. Merino Almazán, T. Sánchez Casanueva, N. García Gomez","doi":"10.1136/ejhpharm-2023-eahp.356","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.356","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"1995 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82444158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信